Patients use it for joint pain, muscle tears, tendon inflammation, and digestive repair (such as ulcers or leaky gut)
Where they overlap and where they don't Complementary Mechanism Targets Target Origin BPC-157 Gastric juice protein fragment (15 amino acids) TB-500 Thymosin Beta-4 fragment (LKKTETQ region) Target Primary action BPC-157 Local tissue repair signaling TB-500 Systemic cell migration and mobilization Target Angiogenesis BPC-157 VEGF upregulation, NO pathway TB-500 Endothelial migration, VEGF crosstalk Target Cell migration BPC-157 Indirect, via growth factors TB-500 Direct (G-actin sequestering) Target Best-evidence tissue BPC-157 Tendon, gut, gastric mucosa (preclinical) TB-500 Cardiac, corneal, skin (preclinical + early human T4) Target Reported in vivo half-life BPC-157 ~4 hours (animal estimates) TB-500 ~23 days (animal estimates) Half-life figures are pharmacokinetic estimates from animal studies
Cattle, Horses, Swine and Sheep - 1 to 2 ml Dogs and Cats - 0.25 to 0.5 ml May be repeated once or twice weekly, as indicated by condition and response
Circadian Rhythm CalibrationSleep Architecture RestorationStress Reduction $95.00 Only the lyophilized product is provided